Associations among pain, non-medical prescription opioid use, and drug overdose history

American Journal on Addictions

Volumn 23, Issue 1, 2014, Pages 41-47

  Bonar, Erin E ^a   Ilgen, Mark A ^a,b   Walton, Maureen ^a   Bohnert, Amy S B ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; NON MEDICAL PRESCRIPTION OPIOID; OPIATE; UNCLASSIFIED DRUG; NARCOTIC ANALGESIC AGENT;

ADULT; AGE; ARTICLE; CAUCASIAN; COCAINE DEPENDENCE; CORRELATIONAL STUDY; DRUG OVERDOSE; DRUG USE; EDUCATION; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; PAIN ASSESSMENT; PRESCRIPTION; RISK FACTOR; SUICIDE ATTEMPT; ADOLESCENT; COMPLICATION; DRUG DEPENDENCE TREATMENT; PSYCHOLOGY; RESIDENTIAL CARE; SELF MEDICATION; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

ADOLESCENT; ADULT; ANALGESICS, OPIOID; DRUG OVERDOSE; FEMALE; HUMANS; LOGISTIC MODELS; MALE; PAIN; RESIDENTIAL TREATMENT; SELF MEDICATION; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS; SUICIDE, ATTEMPTED; YOUNG ADULT;

EID: 84890127890     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/j.1521-0391.2013.12055.x     Document Type: Article

References (49)

1. Bohnert ASB, Roeder K, Ilgen MA., Unintentional overdose and suicide among substance users: A review of overlap and risk factors. Drug Alcohol Depend. 2010; 110: 183-192.
2. Brugal MT, Barrio G, De La Fuente L, et al. Factors associated with non-fatal heroin overdose: Assessing the effect of frequency and route of heroin administration. Addiction. 2002; 97: 319-327.
3. Chen C, Lin K., Health consequences of illegal drug use. Curr Opin Psychiatry. 2009; 22: 287-292.
4. Darke S, Ross J, Hall W., Overdose among heroin users in Sydney, Australia: I. Prevalence and correlates of non-fatal overdose. Addiction. 1996; 91: 405-411.
5. Havens JR, Oser CB, Knudsen HK, et al. Individual and network factors associated with non-fatal overdose among rural Appalachian drug users. Drug Alcohol Depend. 2011; 115: 107-112.
6. Kerr T, Fairbairn N, Tyndall M, et al. Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug Alcohol Depend. 2007; 87: 39-45.
7. Pollini RA, McCall L, Mehta SH, et al. Non-fatal overdose and subsequent drug treatment among injection drug users. Drug Alcohol Depend. 2006; 83: 104-110.
8. Seal KH, Kral AH, Gee L, et al. Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay area, 1998-1999. Am J Public Health. 2001; 91: 1842-1846.
9. Britton PC, Wines JD, Conner KR., Non-fatal overdose in the 12 months following treatment for substance use disorders. Drug Alcohol Depend. 2010; 107: 51-55.
10. Phillips KT, Rosenberg H., The development and evaluation of the harm reduction self-efficacy questionnaire. Psychol Addict Behav. 2008; 22: 36-46.
11. Neale J, Robertson M., Recent life problems and non-fatal overdose among heroin users entering treatment. Addiction. 2005; 100: 168-175.
12. Rossow I, Lauritzen G., Balancing on the edge of death: Suicide attempts and life-threatening overdoses among drug addicts. Addiction. 1999; 94: 209-219.
13. Hall AJ, Logan JE, Toblin RL, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 2008; 300: 2613-2620.
14. Strang J, McCambridge J, Best D, et al. Loss of tolerance and overdose mortality after inpatient opiate detoxification: Follow-up study. BMJ. 2003; 326: 959-960.
15. Davoli M, Bargagli AM, Perucci CA, et al. Risk of fatal overdose during and after specialist drug treatment: The VEdeTTE study, a national multi-site prospective cohort study. Addiction. 2007; 102: 1954-1959.
16. Dunn KM, Saunders KW, Rutter CM, et al. Opioid prescriptions for chronic pain and overdose: A cohort study. Ann Intern Med. 2010; 152: 85-92.
17. Bohnert ASB, Valenstein M, Bair MJ, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011; 305: 1315-1321.
18. Potter JS, Prather K, Weiss RD., Physical pain and associated clinical characteristics in treatment-seeking patients in four substance use disorder treatment modalities. Am J Addict. 2008; 17: 121-125.
19. Trafton JA, Oliva EM, Horst DA, et al. Treatment needs associated with pain in substance use disorder patients: Implications for concurrent treatment. Drug Alcohol Depend. 2004; 73: 23-31.
20. Ballantyne JC, Mao J., Opioid therapy for chronic pain. New Engl J Med. 2003; 349: 1943-1953.
21. Price AM, Ilgen MA, Bohnert ASB., Prevalence and correlates of nonmedical use of prescription opioids in patients seen in a residential drug and alcohol treatment program. J Subst Abuse Treat. 2011; 41: 208-214.
22. Galea S, Nandi R, Coffin PO, et al. Heroin and cocaine dependence and the risk of accidental non-fatal drug overdose. J Addict Dis. 2006; 25: 79-87.
23. Dietze P, Jolley D, Fry C, et al. Transient changes in behaviour lead to heroin overdose: Results from a case-crossover study of non-fatal overdose. Addiction. 2005; 100: 636-642.
24. Paulozzi LJ., Opioid analgesic involvement in drug abuse deaths in American metropolitan areas. Am J Public Health. 2006; 96: 1755-1757.
25. Paulozzi LJ, Xi Y., Recent changes in drug poisoning mortality in the United States by urban-rural status and by drug-type. Pharmacoepidemiol Drug Saf. 2008; 17: 997-1005.
26. Okie S., A flood of opioids, a rising tide of deaths. New Engl J Med. 2010; 363: 1981-1985.
27. Fischer B, Brissette S, Brochu S, et al. Determinants of overdose incidents among illicit opioid users in 5 Canadian cities. CMAJ. 2004; 171: 235-239.
28. Chabal C, Erjavec MK, Jacobson L, et al. Prescription opiate abuse in chronic pain patients: Clinical criteria, incidence, and predictors. Clin J Pain. 1997; 13: 150-155.
29. Hoffmann NG, Oloffson O, Salen B, et al. Prevalence of abuse and dependency in chronic pain patients. Int J Addict. 1995; 30: 919-927.
30. Jonasson U, Jonasson B, Wickstrom L, et al. Analgesic use disorders among orthopedic and chronic pain patients at a rehabilitation clinic. Subst Use Misuse. 1998; 33: 1375-1385.
31. Kouyanou K, Pither CE, Wessely S., Medication misuse, abuse and dependence in chronic pain patients. J Psychosom Res. 1997; 43: 497-504.
32. Turk DC, Swanson KS, Gatchel RJ., Predicting opioid misuse by chronic pain patients: A systematic review and literature synthesis. Clin J Pain. 2008; 24: 497-508.
33. Substance Abuse and Mental Health Services Administration. Results from the 2009 National Survey on Drug Use and Health: Volume 1. Summary of National Findings. Office of Applied Studies. NSDUH Series H-38A, HHS Pub. No. SMA 10-4586, Rockville, MD; 2010.
34. Boyd CJ, Teter CJ, West BT, et al. Non-medical use of prescription analgesics: A three-year national longitudinal study. J Addict Dis. 2009; 28: 232-242.
35. Becker WC, Sullivan LE, Tetrault JM, et al. Non-medical use, abuse and dependence on prescription opioids among U.S. adults: Psychiatric, medical and substance use correlates. Drug Alcohol Depend. 2008; 94: 38-47.
36. Farrar JT, Young JP, LaMoreaux L, et al. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001; 94: 149-158.
37. Butler SF, Budman SH, Fernandez KC, et al. Development and validation of the current opioid misuse measure. Pain. 2007; 130: 144-156.
38. Butler SF, Budman SH, Fanciullo GJ, et al. Cross validation of the current opioid misuse measure to monitor chronic pain patients on opioid therapy. Clin J Pain. 2010; 26: 770-776.
39. McLellan AT, Luborsky L, Woody GE, et al. An improved diagnostic evaluation instrument for substance abuse patients: The addiction severity index. J Nerv Ment Dis. 1980; 168: 26-33.
40. Rosen CS, Henson BR, Finney JW, et al. Consistency of self-administered and interview-based Addiction Severity Index composite scores. Addiction. 2000; 95: 419-425.
41. Ochoa KC, Hahn JA, Seal KH, et al. Overdosing among young injection drug users in San Francisco. Addict Behav. 2001; 26: 453-460.
42. McLellan AT, Kushner H, Metzger D, et al. The fifth edition of the Addiction Severity Index. J Subst Abuse Treat. 1992; 9: 199-213.
43. Beck AT, Steer RA., Beck Scale for Suicide Ideation Manual, San Antonio, TX: Psychological Corporation; 1993.
44. Beck AT, Steer RA, Ranieri WF., Scale for suicide ideation: Psychometric properties of a self-report version. J Clin Psychol. 1988; 44: 499-505.
45. Holmbeck GN., Toward terminological, conceptual, and statistical clarity in the study of mediators and moderators: Examples from child-clinical and pediatric psychology literatures. J Consult Clin Psychol. 1997; 65: 599-610.
46. Ilgen MA, Roeder KM, Webster L, et al. Measuring pain medication expectancies in adults treated for substance use disorders. Drug Alcohol Depend. 2011; 115: 51-56.
47. Khosla N, Juon HS, Kirk GD, et al. Correlates of non-medical prescription drug use among a cohort of injection drug users in Baltimore City. Addict Behav. 2011; 36: 1282-1287.
48. Coffin PO, Tracy M, Bucciarelli A, et al. Identifying injection drug users at risk of nonfatal overdose. Acad Emerg Med. 2007; 14: 616-623.
49. Pattinson KTS., Opioids and the control of respiration. Br J Anaesth. 2008; 100: 747-758.